Mode
Text Size
Log in / Sign up

Meta-analysis shows intermittent fasting lowers BMI and fasting glucose in women with overweight or obesityIntermittent Fasting Works for Weight Loss But Has a Catch

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider intermittent fasting for BMI and glucose in women, but note heterogeneity and need for more trials.

This meta-analysis evaluated the effects of intermittent fasting on metabolic parameters in women with overweight or obesity. The pooled analysis included 1287 participants across multiple studies. The primary outcome was not reported, but secondary outcomes included BMI, fasting blood glucose, and blood pressure.

The analysis demonstrated that intermittent fasting significantly reduced BMI in the final model after excluding one influential study. The mean difference was -0.41 with a 95% CI of -0.81 to -0.02 and a P value of 0.0396. Fasting blood glucose also showed a significant reduction with a mean difference of -2.18 and a 95% CI of -3.20 to -1.16, with a P value less than 0.0001.

In contrast, no significant effect was observed on blood pressure. The authors highlighted substantial heterogeneity in the initial BMI model with an I2 value of 80.2%. Several subgroup estimates were based on limited evidence, and variation in intervention and comparator conditions was noted.

The certainty of the available evidence is limited due to heterogeneity and possible co-interventions. While intermittent fasting may improve BMI and fasting blood glucose in this population, further well-designed trials are needed to confirm findings and refine practical recommendations.

More than 4 in 10 women in the United States have obesity. Another 3 in 10 have overweight. That means most women carry extra weight that can raise their risk for diabetes, heart disease, and other health problems.

Doctors often recommend diet and exercise first. But traditional diets are hard to stick with. You count calories, measure portions, and feel hungry all the time.

Intermittent fasting offers a different approach. Instead of focusing on what you eat, it focuses on when you eat. Some people skip breakfast and eat only between noon and 8 p.m. Others eat normally five days a week and cut calories two days.

The appeal is obvious. No special foods to buy. No complicated math. Just a schedule.

What the Old Thinking Got Wrong

For years, many doctors dismissed intermittent fasting as a fad. They said it was just another way to eat fewer calories. Nothing special about the timing.

But here's the twist: this new research suggests the timing itself may matter.

The analysis looked at 22 randomized controlled trials (the gold standard in medical research). Women with overweight or obesity followed various fasting schedules. Researchers tracked their body mass index (BMI), fasting blood sugar, and blood pressure.

The results showed real changes that went beyond simple calorie cutting.

How Intermittent Fasting Works Inside Your Body

Think of your body like a house with two power sources. During the day, you run on solar panels (the food you eat). At night, you switch to battery backup (stored fat).

When you fast for 12 to 16 hours, your body runs out of solar power. It has no choice but to tap into the battery. That stored fat gets burned for energy.

This process is called metabolic switching. It's not magic. It's biology.

Your body also becomes more sensitive to insulin during fasting. Insulin is the hormone that tells your cells to take in sugar from your blood. When your cells listen better, your blood sugar drops. That's a good thing.

The researchers combined data from 22 studies with 1,287 women. They used strict methods to make sure their results were reliable.

Here's what they found:

Women who did intermittent fasting lost weight. Their BMI dropped by about half a point on average. That may sound small, but it's meaningful. A half-point drop in BMI for a 5-foot-5 woman means losing about 3 pounds.

More importantly, their fasting blood sugar dropped by about 2 points. That's a significant improvement. High blood sugar is a warning sign for diabetes.

But blood pressure did not change at all. Not even a little.

The sweet spot for results seemed to be fasting about twice per week. The total hours of fasting mattered less than the consistency.

But There's a Catch

The results look promising, but they come with a warning label.

The studies varied widely. Some used different fasting schedules. Some compared fasting to regular dieting. Others compared it to doing nothing at all.

When the researchers looked closer, they found that some of the weight loss results depended on which studies they included. Remove one study, and the numbers changed.

This doesn't mean the results are wrong. It means they're not as solid as we'd like.

If you're a woman with overweight or obesity, intermittent fasting could help you lose weight and lower your blood sugar. The research suggests trying a schedule of fasting about two days per week.

But don't expect it to fix your blood pressure. That may require other changes like reducing salt, exercising more, or taking medication.

Talk to your doctor before starting any fasting plan. This is especially important if you have diabetes, take medications, or have a history of eating disorders.

The Honest Truth About the Research

This analysis has real limits. The studies were relatively short. Most lasted only a few months. We don't know what happens after a year or two.

The women in the studies were mostly in their 40s and 50s. We can't be sure the results apply to younger women or older adults.

Some studies were small. A few had only 20 or 30 women. Small studies are less reliable than large ones.

The researchers also noted that some women in the fasting groups may have been doing other healthy things at the same time. Maybe they exercised more or ate better quality food. It's hard to separate the effects of fasting from everything else.

What Happens Next

The researchers call for larger, longer studies to confirm these findings. They want to know which fasting schedule works best and for whom.

Right now, intermittent fasting is a tool, not a cure. It may help some women lose weight and control blood sugar. But it's not a replacement for medical care or healthy habits.

Science moves slowly for a reason. We need to be sure before making broad recommendations. For now, the evidence says intermittent fasting can help. But it's not the whole answer.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
This study aimed to assess the effects of intermittent fasting (IF) on prespecified clinically relevant outcomes, including BMI, fasting blood glucose (FBG), and blood pressure, in women with overweight or obesity, and to explore the dose–response relationship and moderating factors of the intervention. Following PRISMA guidelines, we systematically searched PubMed, Web of Science, PsycINFO, and the Cochrane Library (up to August 1, 2025) for eligible randomized controlled trials (RCTs). Twenty-two studies involving 1,287 women with overweight or obesity were included. Mean differences (MD) were pooled using a restricted maximum likelihood random-effects model (REML). Heterogeneity was evaluated via I2 and Q tests, while publication bias was assessed using sensitivity analyses, Egger's regression, and the trim-and-fill method. Subgroup analyses, meta-regression, and nonlinear dose–response models were used to identify moderators. IF significantly reduced BMI in the final BMI model after exclusion of one influential study (MD = −0.41, 95% CI: −0.81 to−0.02, P = 0.0396) and FBG (MD = −2.18, 95% CI:−3.20 to−1.16, P < 0.0001) in women with overweight or obesity, with no significant effect on blood pressure. The initial BMI model showed substantial heterogeneity (I2 = 80.2%). Subgroup analyses suggested variability across intervention characteristics and participant strata, but these findings should be interpreted cautiously because several subgroup estimates were based on limited evidence. Dose–response analysis suggested a relatively favorable modeled frequency around twice weekly, with effects remaining relatively stable across 1,285–2,895 total intervention hours. IF may improve BMI and FBG in women with overweight or obesity, whereas no significant effects were observed for blood pressure outcomes. The dose–response findings suggest potentially favorable intervention patterns, but these should be interpreted cautiously because of heterogeneity across studies, variation in intervention and comparator conditions, possible co-interventions, and the limited certainty of the available evidence. Further well-designed trials are needed to confirm these findings and refine practical recommendations. https://www.crd.york.ac.uk/PROSPERO/view/CRD420251178671, identifier: CRD420251178671.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.